Tirzepatide online access for Brookings, South Dakota
Company statements checked between September 10, 2026 and September 23, 2026: 2 covered companies — Gentle Health and GoodRx Care — advertise online access to Tirzepatide for patients in South Dakota, including Brookings. Confirm eligibility and total charges with the provider.
Browse online Tirzepatide programs advertised for patients in Brookings, South Dakota, with state-level access evidence.
Inside Telehealth Editorial · Updated
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| Gentle Health | Compounded injectable tirzepatide | $169/mo advertised monthly bundle, Compounded injectable tirzepatide | Official site ↗ | |
| GoodRx Care | Zepbound KwikPen | $338/mo partial monthly subtotal, Zepbound KwikPen | Official site ↗ |
Health context in Brookings
Tirzepatide programs are marketed for weight management and, for some products, type 2 diabetes. These Brookings figures give local context only. Among the 5 South Dakota cities in this research set, Brookings has the highest estimate for obesity among adults (40.2%) and the lowest estimate for lack of health insurance among adults aged 18–64 (7.8%).
| Measure | Brookings | 95% range | Among the 5 South Dakota cities in this research set | Year |
|---|---|---|---|---|
| Obesity among adults | 40.2% | 35.7–44.9% | highest | 2023 |
| Diagnosed diabetes among adults | 10.1% | 8.9–11.4% | tied for second-highest | 2023 |
| High blood pressure among adults | 29.2% | 26.5–32.1% | third-highest | 2023 |
| Lack of health insurance among adults aged 18–64 | 7.8% | 6.6–9.1% | lowest | 2023 |
| Routine checkup in the past year among adults | 75.6% | 72.5–78.5% | third-highest | 2023 |
Source: CDC PLACES, 2025 release — model-based estimates from the Behavioral Risk Factor Surveillance System for Census place geography (total population 23,377); each measure is an estimate for adults. These describe the city's adults as a group; they do not indicate whether any person is eligible for, or should use, a treatment listed here.
This tirzepatide page is the Brookings entry point to the South Dakota statewide online listing, not evidence of an office, pharmacy or clinician in Brookings. Each company below appears because its named products have their own South Dakota evidence; the heading does not extend coverage to every medicine in the category, and branded and compounded products are listed separately.
Use the South Dakota guide to compare the listed programs, their separate prices and their billing and cancellation terms before choosing which offer to ask a company about.
These are online services advertised for patients in South Dakota, listed alphabetically. They are not verified offices, pharmacies or clinicians located in Brookings, and a listing is not a prescription, appointment or coverage guarantee. Read the South Dakota Tirzepatide guide for product details, charges and limitations.
Selected providers
Gentle Health
Gentle Health's compounded injectable tirzepatide program, if prescribed, billed through its medication-order subscription.
Compounded injectable tirzepatide (injection): 2.5–5 mg/week — $169/mo · >5–10 mg/week — $219/mo · >10–15 mg/week — $269/mo
- Compounded injectable tirzepatide — injection: state evidence checked · Availability source · Full evidence notes
Official provider website · Product and access details
Medical Director: James Simmons, MD — company-reported; see profile for the source.
GoodRx Care
GoodRx Care Direct's separately priced branded tirzepatide pen, billed apart from its monthly membership fee.
Zepbound KwikPen (pen): introductory KwikPen strength (page labels it 10 mg) — $338/mo
- Zepbound KwikPen — pen: state evidence checked · Availability source · Full evidence notes
More listings
Other medications for Brookings: GLP-1 medication access · Semaglutide
Tirzepatide in other South Dakota cities: Aberdeen · Rapid City · Sioux Falls · Watertown
Before requesting a prescription
Confirm the named product is offered where you will be during the visit, check eligibility, total charges and any supply commitment, and ask what happens if you need in-person care. This listing does not assess which treatment is right for you.